| Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges S Laurent, AA Saei, S Behzadi, A Panahifar, M Mahmoudi Expert opinion on drug delivery 11 (9), 1449-1470, 2014 | 532 | 2014 |
| Proteome integral solubility alteration: a high-throughput proteomics assay for target deconvolution M Gaetani, P Sabatier, AA Saei, CM Beusch, Z Yang, SL Lundström, ... Journal of proteome research 18 (11), 4027-4037, 2019 | 226 | 2019 |
| Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges Z Bakhtiary, AA Saei, MJ Hajipour, M Raoufi, O Vermesh, M Mahmoudi Nanomedicine: Nanotechnology, Biology and Medicine 12 (2), 287-307, 2016 | 217 | 2016 |
| Electrochemical biosensors for glucose based on metal nanoparticles AA Saei, JE NazhadDolatabadi, P Najafi-Marandi, A Abhari, M Guardia TrAC Trends in Analytical Chemistry, 2013 | 205 | 2013 |
| Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer M Azhdarzadeh, F Atyabi, AA Saei, BS Varnamkhasti, Y Omidi, M Fateh, ... Colloids and Surfaces B: Biointerfaces 143, 224-232, 2016 | 165 | 2016 |
| Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug X Zhang, K Selvaraju, AA Saei, P D'Arcy, RA Zubarev, ESJ Arnér, ... Biochimie 162, 46-54, 2019 | 159 | 2019 |
| Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging S Sharifi, H Seyednejad, S Laurent, F Atyabi, AA Saei, M Mahmoudi Contrast media & molecular imaging 10 (5), 329-355, 2015 | 149 | 2015 |
| Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer Z Bakhtiary, J Barar, A Aghanejad, AA Saei, E Nemati, ... Drug development and industrial pharmacy 43 (8), 1244-1253, 2017 | 142 | 2017 |
| Nanoparticle surface functionality dictates cellular and systemic toxicity AA Saei, M Yazdani, SE Lohse, Z Bakhtiary, V Serpooshan, M Ghavami, ... Chemistry of Materials 29 (16), 6578-6595, 2017 | 112 | 2017 |
| Cellular toxicity of nanogenomedicine in MCF-7 cell line: MTT assay S Ahmadian, J Barar, AA Saei, MAA Fakhree, Y Omidi Journal of visualized experiments: JoVE, 1191, 2009 | 105 | 2009 |
| Nanotoxicology: advances and pitfalls in research methodology M Azhdarzadeh, AA Saei, S Sharifi, MJ Hajipour, AM Alkilany, ... Nanomedicine 10 (18), 2931-2952, 2015 | 99 | 2015 |
| Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin AA Saei, H Gullberg, P Sabatier, CM Beusch, K Johansson, B Lundgren, ... Redox biology 32, 101491, 2020 | 87 | 2020 |
| An update to space biomedical research: tissue engineering in microgravity bioreactors A Barzegari, AA Saei BioImpacts: BI 2 (1), 23, 2012 | 87 | 2012 |
| ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery AA Saei, CM Beusch, A Chernobrovkin, P Sabatier, B Zhang, ÜG Tokat, ... Nature communications 10 (1), 5715, 2019 | 74 | 2019 |
| The microbiome: the forgotten organ of the astronaut’s body–probiotics beyond terrestrial limits AA Saei, A Barzegari Future microbiology 7 (9), 1037-1046, 2012 | 72 | 2012 |
| Nanotechnology for targeted detection and removal of bacteria: opportunities and challenges MJ Hajipour, AA Saei, ED Walker, B Conley, Y Omidi, KB Lee, ... Advanced Science 8 (21), 2100556, 2021 | 65 | 2021 |
| System-wide identification and prioritization of enzyme substrates by thermal analysis AA Saei, CM Beusch, P Sabatier, JA Wells, H Gharibi, Z Meng, ... Nature communications 12 (1), 1296, 2021 | 65* | 2021 |
| Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine P Ghanbari, M Mohseni, M Tabasinezhad, B Yousefi, AA Saei, S Sharifi, ... Applied biochemistry and biotechnology 174, 667-681, 2014 | 60 | 2014 |
| Sphingosin 1-phosphate contributes in tumor progression M Tabasinezhad, N Samadi, P Ghanbari, M Mohseni, AA Saei, S Sharifi, ... Journal of cancer research and therapeutics 9 (4), 556-563, 2013 | 59 | 2013 |
| DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies M Mirza-Aghazadeh-Attari, C Ostadian, AA Saei, A Mihanfar, SG Darband, ... DNA repair 80, 59-84, 2019 | 52 | 2019 |
roman zubarevKarolinska InstitutetΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ki.se
